Research and Developement of Herbal Medicine(Taeumbiman-tang) on Obesity

복합한약물(가칭; 태음비만탕)을 이용한 비만치료약물 개발을 위한 연구

  • Kwak, Chang-Kyu (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Sohn, Eun-Hae (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Yoo, Jung-Hee (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Koh, Byung-Hee (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Song, Il-Byung (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Lee, Eui-Ju (Institute of Oriental Medicine, Kyunghee University)
  • 곽창규 (경희대학교 한의과대학 사상체질과) ;
  • 손은혜 (경희대학교 한의과대학 사상체질과) ;
  • 유정희 (경희대학교 한의과대학 사상체질과) ;
  • 고병희 (경희대학교 한의과대학 사상체질과) ;
  • 송일병 (경희대학교 한의과대학 사상체질과) ;
  • 이의주 (경희대학교 한의학연구소)
  • Published : 2005.04.25

Abstract

A Korean traditional herbal formular, Taeumbiman-tang(TBT), was based on Taeumjowi-tang, currently the most widely used herbal formula compound, and which is known to be safe and have a positive effect on adult obesity. TBT was given to obese children for thirty days, and was found to be clinically safe and effective. The subjects were children who had been admitted into the hospital to be treated for obesity, that had more than 20% relative body weight. Originally there were 19 subjects, but 5 dropped out of the experiment. There were 5 girls and 9 boys, whose average ages were $11.00\;{\pm}\;2.60$ years, average weight was $54.01\;{\pm}\;18.59\;kg$. As a pretest, all of the volunteers were examined for height, weight, blood pressure, pulse rate, EKG, and chest radiography. The subjects underwent interview, body measurement tests, blood tests, and safety tests under 8 hour fasting state. After 15 days of TBT intake, the safety tests and the interview were conducted. The interview, body measurement tests, blood tests, and safety tests were conducted again after the 30 day trial was completed. The short term effects of TBT on obese children is weight loss. It did not cause any significant changes in the subject's livers, hearts, and kidneys, and clinically dangerous side effects or withdrawal symptoms were not observed.

Keywords

References

  1. World Health Organization, Preventing and managing the global epidemic, Geneva: WHO, 1997.
  2. 박성규, 김용주, 신재훈, 이항. 서울지역 초등학교 학생들의 신체계측치를 이용한 Nutritional Status의 변화에 대한 연구. 소아과학회지 42, 311-323, 1999.
  3. 홍영미, 문경래, 서정완, 심재건, 유기환, 정병주. 소아 비만의 진단과 치료지침. 소아과학회지 42, 1338-1345, 1999.
  4. Power, C, Lake, J.L., Cole, T.J. Measurement and long-term risks of child and adolescent fatness. Int J Obes Metab Dis 21, 507-526, 1997.
  5. Fruhbeck, G. Childhood obesity: time for action, not complacency. BMJ 320, 328-329, 2000
  6. 대한비만학회, 임상비만학, 417-418, 고려의학, 서울, 1995.
  7. Lenz, T.L., Hamilton, W.K Supplemental products used for weight loss. J Am Pharm Assoc (Wash DC). 44(1):59-67; quiz 67-68, 2004 Jan-Feb.
  8. 이성두, 박순달, 변준석, 지골피가 고지방식이로 유발된 백서의 고지혈증에 미치는 영향. 한방내과학회지 19(2) : 347-366, 1999.
  9. 한무규, 서해경, 김은하. 대시호탕이 고지방식이로 유발한 비만 흰쥐의 체중 및 생화학적 변화에 미치는 영향. 대한추나학회 2(1):177-186, 2001.
  10. 최원호, 서부일. 체감의이인탕이 고지방식이로 유발한 비만흰쥐의 생화학 및 조직화학적 변호에 미치는 영향. 대한한의학회지. 21(3):31-39, 2000.
  11. 김상찬, 권영규, 김연섭, 변성희. 비만 치료 및 예방에 대한 한약의 효능 연구(VII) -체감행혈의이인탕가옥미수가 비만유도 흰쥐의 생화학적 변화에 미치는 영향-. 동의생리병리학회지 16(5):1001-1008, 2002
  12. 이기주, 김경요, 전병훈. 태음조위탕이 백서의 비만증 및 유도비만세포에 미치는 효과. 사상의학회지 8(2):219-238, 1996.
  13. 신동준, 김달래, 김선형. 태음조위탕과 마황이 비만 백서의 Leptin에 미치는 영향. 사상의학회지. 13(1):79-87, 2001
  14. Molnar, D., Torok, K, Erhardt E, Jeges S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int J Obes Relat Metab Disord 24(12):1573-1578, 2000.
  15. 김달래, 백태현. 사상체질과 비만의 상관성에 관한 임상적 연구. 사상의학회지 8(1):319-335, 1996.
  16. 전국사상의학교실, 사상의학, 149-176, 집문당, 서울, 2004
  17. 대한소아과학회 보건통계위원회, 1998년 한국소아 및 청소년 신체 발육 표준치 세부자료, 1998.
  18. Friedewald, W.T., Levy, RI., Fredrickson, D.s. Estimation of concentration of low densty lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502, 1972.
  19. Smith, S.C. Jr. Need for a paradigm shiff: the importance of risk factor reduction therapy in treating patients with cardiovascular disease. Am J Cardiol 82, 10T-13T, 1998.
  20. Matthews, D.R, Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations. Colestrol in childhood. Padiatr 101, 141-147, 1998.
  21. Van der Hoeft. C.S., Stricker, B.H. Ephedrine and ephedra in weight loss products and other preparations. Ned Tijdschr Geneeskd 146(28):1335-1336, 2002.
  22. Lenz, T.L., Hamilton, W.R Supplemental products used for weight loss. J Am Pharm Assoc (Wash DC). 44(1):59-67; quiz67-68, 2004.